Nanotechnology is playing a crucial role in combating infectious and inflammatory diseases by offering innovative solutions for prevention, treatment, and detection. This review discusses the various types of nanoparticles (NPs) and their applications in addressing these diseases. NPs, such as metal NPs, carbon-based NPs, lipid NPs, polymeric NPs, protein-based NPs, and exosomes, have unique properties that make them effective for vaccine development, drug delivery, and pathogen detection. Metal NPs, like gold and silver nanoparticles, are used for their antibacterial and antiviral properties, while carbon-based NPs are valued for their high surface area and drug-loading capacity. Lipid NPs are effective for delivering mRNA vaccines, such as those used for SARS-CoV-2. Polymeric NPs are used as vaccine adjuvants and drug delivery systems, while protein-based NPs and exosomes are used for targeted delivery and immunomodulation. Challenges in clinical translation include ensuring the safety, stability, and efficiency of NP-based therapies. Despite these challenges, nanotechnology offers promising advancements in the treatment of infectious and inflammatory diseases, with ongoing research aimed at improving their effectiveness and applicability. The review highlights the potential of NPs in enhancing immune responses, improving drug delivery, and enabling more accurate diagnostics, ultimately contributing to the comprehensive management of these diseases.Nanotechnology is playing a crucial role in combating infectious and inflammatory diseases by offering innovative solutions for prevention, treatment, and detection. This review discusses the various types of nanoparticles (NPs) and their applications in addressing these diseases. NPs, such as metal NPs, carbon-based NPs, lipid NPs, polymeric NPs, protein-based NPs, and exosomes, have unique properties that make them effective for vaccine development, drug delivery, and pathogen detection. Metal NPs, like gold and silver nanoparticles, are used for their antibacterial and antiviral properties, while carbon-based NPs are valued for their high surface area and drug-loading capacity. Lipid NPs are effective for delivering mRNA vaccines, such as those used for SARS-CoV-2. Polymeric NPs are used as vaccine adjuvants and drug delivery systems, while protein-based NPs and exosomes are used for targeted delivery and immunomodulation. Challenges in clinical translation include ensuring the safety, stability, and efficiency of NP-based therapies. Despite these challenges, nanotechnology offers promising advancements in the treatment of infectious and inflammatory diseases, with ongoing research aimed at improving their effectiveness and applicability. The review highlights the potential of NPs in enhancing immune responses, improving drug delivery, and enabling more accurate diagnostics, ultimately contributing to the comprehensive management of these diseases.